MediWound (MDWD) Current Deferred Revenue (2016 - 2020)
MediWound (MDWD) posted quarterly Current Deferred Revenue of $462000.0 for Q4 2020, up 85.54% year-over-year from $249000.0 in Q1 2020, and up 85.54% quarter-over-quarter from $249000.0 in Q4 2019.
MediWound (MDWD) Current Deferred Revenue (2016 - 2020) Analysis & Trends
MediWound's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $462000.0 for Q4 2020.
- In Q4 2020, Current Deferred Revenue rose 85.54% year-over-year to $462000.0; the TTM figure through Dec 2020 stood at $462000.0 (up 85.54% YoY), while the FY2020 annual figure was $462000.0, up 85.54% from the prior year.
- Current Deferred Revenue for Q4 2020 stood at $462000.0, up from $249000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $462000.0 in Q4 2020, with the low at $122000.0 in Q4 2016.
- The 5-year median for Current Deferred Revenue is $198000.0 (2018), against an average of $232400.0.
- The sharpest annual moves came in 2017 and 2020: Current Deferred Revenue gained 7.38% in 2017, then jumped 85.54% in 2020.
- MediWound's Current Deferred Revenue stood at $122000.0 in 2016, then increased by 7.38% to $131000.0 in 2017, then jumped by 51.15% to $198000.0 in 2018, then climbed by 25.76% to $249000.0 in 2019, then surged by 85.54% to $462000.0 in 2020.
- Business Quant data shows MDWD's Current Deferred Revenue at $462000.0 in Q4 2020, $249000.0 in Q4 2019, and $198000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 462,000.00 |
| Dec 31, 2019 | 249,000.00 |
| Dec 31, 2018 | 198,000.00 |
| Dec 31, 2017 | 131,000.00 |
| Dec 31, 2016 | 122,000.00 |